Release Date: 2022-03-15

Molecular Mechanisms of Neurodegeneration

Release Date: 2022-03-15

Media Type
  • PDF

Buy from

Price may vary by retailers

Work TypeBook Chapter
Published inA Handbook on Chemobrain with Molecular and Clinical Background
First Page7
Last Page10
DOIhttps://doi.org/10.69860/nobel.9786053358985.2
ISBN978-605-335-898-5 (PDF)
LanguageENG
Page Count4
Copyright HolderNobel Tıp Kitabevleri
Licensehttps://nobelpub.com/publish-with-us/copyright-and-licensing
  • Behl C. Estrogen as a neuroprotective hormone. Nat Rev Neurosci. 2002; 3: 433-42.

  • Berliocchi L, Bano D, Nicotera P. Ca2+ signals and death programmes in neurons. Philos Trans R Soc Lond B Biol Sci. 2005; 360: 2255-8.

  • Currie LJ, Harrison MB, Trugman JM, et al. Postmenopausal estrogen use affects risk for Parkinson disease. Arch Neurol. 2004; 61: 886–8.

  • Dingledine R, Borges K, Bowie D, et al. The glutamate receptor ion channels. Pharmacol Rev. 1999; 51: 7–61.

  • Greenamyre JT, Porter RH. Anatomy and physiology of glutamate in the CNS. Neurology. 1994; 44: 7–13.

  • Herrup K. The involvement of cell cycle events in the pathogenesis of Alzheimer’s disease. Alzheimer’s Research & Therapy. 2010; 2: 13.

  • Kawas C, Resnick S, Morrison A, et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer’s disease: the Baltimore Longitudinal Study of Aging. Neurology. 1997; 48: 1517-21.

  • Lee H, Casadesus G, Zhu X, et al. Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer’s disease. Neurochem Int. 2009: 54: 84-88.

  • Liou AK, Zhou Z, Pei W, et al. BimEL up-regulation potentiates AIF translocation and cell death in response to MPTP. Faseb J. 2005; 19: 1350-2.

  • Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med. 1994; 330: 613-22.

  • Liu T, Perry G, Chan HW, et al. Amyloid-beta-induced toxicity of primary neurons is dependent upon differentiation-associated increases in tau and cyclindependent kinase 5 expression. J Neurochem. 2004; 88: 554-63.

  • Lucas DR, Newhouse JP. The toxic effect of sodium L-glutamate on the inner layers of the retina. AMA Arch Ophthalmol. 1957; 58: 193-201.

  • Marder K, Tang MX, Alfaro B, et al. Postmenopausal estrogen use and Parkinson’s disease with and without dementia. Neurology. 1998; 50: 1141-3.

  • Nagy Z, Combrinck M, Budge M, et al. Cell cycle kinesis in lymphocytes in the diagnosis of Alzheimer’s disease. Neuroscience Letters. 2001: 317: 81-4.

  • Raghupathi R. Cell death mechanisms following traumatic brain injury. Brain Pathol. 2004; 14: 215-22.

  • Raynaud F, Marcilhac A. Implication of calpain in neuronal apoptosis: A possible regulation of Alzheimer’s Disease. FEBS Journal. 2006; 273: 3437-43.

  • Rothman SM, Olney JW. Excitotoxicity and the NMDA receptor–still lethal after eight years. Trends Neurosci. 1995; 18: 57-8.

  • Schmetsdorf S, Gärtner U, Arendt T. Expression of cell cycle-related proteins in developing and adult mouse hippocampus. Int J Dev Neurosci. 2005: 23: 101-12.

  • Tang MX, Jacobs D, Stern Y, et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer’s disease. The Lancet. 1996; 348: 429-32.

  • Yang Y, Herrup K. Protective response or lethal event in post-mitotic neurons? Biochimica et Biophysica Acta. 2007: 1772: 457-66.

  • Zhu B, Pennack JA, McQuilton P, et al. Drosophila Neurotrophins Reveal a Common Mechanism for Nervous System Formation. PLoS Biol. 2008: 6: e284.

Share This Chapter!